Drug Approval | March 22, 2023
Zydus granted Orphan Drug Designation by USFDA for ZYIL1
ZYIL1 is a novel oral small molecule NLRP3 inhibitor which has demonstrated CSF penetration in non-human primates
ZYIL1 is a novel oral small molecule NLRP3 inhibitor which has demonstrated CSF penetration in non-human primates
All children (100%) in the presymptomatic intravenous cohort of LT-002 maintained or achieved all assessed motor milestones, including independent walking
The Phase 3 data presented at AAD include a comprehensive review of the THRIVE-AA2 results and further elaborate the topline data reported in August 2022
The one-year-long study was aimed to evaluate the efficacy of LDH's digital therapeutics platform
He is Proficient in overseeing and leading teams for running successful business operations
This is especially the case if the patients are young, have multiple blocks & have conditions that may make angioplasty to implant drug-eluting stents ineffective
Man Industries (India) Limited has received a new export order of approximately Rs. 1,300 crores.
KRIVIDA TRIVUS detects the specific virus causing a respiratory infection.
Expands robotics to 20+ specialities
New Building at Rockford, Illinois site will significantly increase equipment and capacity for injectable biologics and other self-administered therapies
Subscribe To Our Newsletter & Stay Updated
